J Paul Monk (Paul Monk)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Radical Prostatectomy

Histone Deacetylase

Patient Reported

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer chemotherapy and pharmacology

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Wassim Abida, Andrew W Hahn, Neal D Shore, Archana M Agarwal, Paul R Sieber, Matthew R Smith, Tanya Barauskas Dorff, J Paul Monk, Matthew B Rettig, Rupal Patel, Anne Page, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Aleksandr Pankov, Amber Wang, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Christopher L Logothetis, Michael J Morris
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Wassim Abida, Andrew W Hahn, Neal D Shore, Archana M Agarwal, Paul R Sieber, Matthew R Smith, Tanya Barauskas Dorff, J Paul Monk, Matthew B Rettig, Rupal Patel, Anne Page, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Aleksandr Pankov, Amber Wang, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Christopher L Logothetis, Michael J Morris
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Wassim Abida, Andrew W Hahn, Neal D Shore, Archana M Agarwal, Paul R Sieber, Matthew R Smith, Tanya Barauskas Dorff, J Paul Monk, Matthew B Rettig, Rupal Patel, Anne Page, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Aleksandr Pankov, Amber Wang, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Christopher L Logothetis, Michael J Morris
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Wassim Abida, Andrew W Hahn, Neal D Shore, Archana M Agarwal, Paul R Sieber, Matthew R Smith, Tanya Barauskas Dorff, J Paul Monk, Matthew B Rettig, Rupal Patel, Anne Page, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Aleksandr Pankov, Amber Wang, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Christopher L Logothetis, Michael J Morris
Phase 1 Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer Progressing on Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Katharine A Collier, Hugo Valencia, Herbert Newton, Erinn M Hade, Douglas W Sborov, Robert Cavaliere, Ming J Poi, Mitch A Phelps, Sophia G Liva, Christopher C Coss, Jiang Wang, Soun Khountham, J Paul Monk, Charles L Shapiro, Richard L Piekarz, Craig C Hofmeister, D Bradley Welling, Amir Mortazavi
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies. Cancer chemotherapy and pharmacology 87 (5) (2021)
J Paul Monk, Glenn Liu, Walter M Stadler, Susan Geyer, Ying Huang, John Wright, Miguel Villalona-Calero, James Wade, Russell Szmulewitz, Shilpa Gupta, Amir Mortazavi, Robert Dreicer, Roberto Pili, Nancy Dawson, Saby George, Jorge A Garcia
Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Investigational new drugs 36 (5) (2018)